A5050400327- Menopause: Health Impacts and Treatments
- Lung Cancer Treatments and Mutations
- HIV/AIDS Research and Interventions
- Inflammatory Biomarkers in Disease Prognosis
- Menstrual Health and Disorders
- Cancer Immunotherapy and Biomarkers
- Reproductive Health and Contraception
- Gastric Cancer Management and Outcomes
- Phytoestrogen effects and research
- Palliative Care and End-of-Life Issues
- Head and Neck Cancer Studies
- Immune cells in cancer
- Sexual Assault and Victimization Studies
- Global Maternal and Child Health
- Sex and Gender in Healthcare
- Childhood Cancer Survivors' Quality of Life
- Primary Care and Health Outcomes
- Colorectal Cancer Treatments and Studies
- Obesity and Health Practices
- Workplace Violence and Bullying
- Cancer survivorship and care
- Estrogen and related hormone effects
- Economic and Financial Impacts of Cancer
- Endometriosis Research and Treatment
- Medical Malpractice and Liability Issues
NHS Lothian
2022-2025
Western General Hospital
2022-2025
Edinburgh Cancer Research
2021-2022
NHS Fife
2019
Community Health Center
2009
Yale University
2007
•Biomarkers of systemic inflammation are strong prognostic factors in patients with NSCLC.•The Scottish Inflammatory Prognostic Score is a simple score combining albumin and neutrophil count.•SIPS objectively stratifies survival clinically meaningful timeframe. IntroductionPembrolizumab an established first-line option for advanced non-small-cell lung cancer (NSCLC) expressing programmed death-ligand 1 ≥50%. Durable responses seen subset patients; however, many derive little clinical...
Introduction: Despite significant advances in systemic anticancer therapy (SACT) for non-small cell lung cancer (NSCLC), many patients still fail to respond treatment or develop resistance. Albumin, a biomarker of inflammation and malnutrition, predicts survival cancers. We evaluated the prognostic significance albumin receiving first-line targeted immunotherapy-based SACT metastatic NSCLC. Methods: All treated with NSCLC at regional Scottish centre were identified. Serum pre-treatment,...
The decision to undergo chemotherapy for incurable cancer demands informed discussions about the risks and benefits of proposed treatments. Research has shown that many patients have a poor grasp these factors.An evaluation patient experience palliative decision-making was undertaken. Patients with lung or gynaecological cancers were surveyed their decision, what they understood its benefits, how supported felt.A total 29 people (n = 21) 8) completed questionnaires. majority felt sure though...